"Rising drug prices affect uninsured or underinsured patients, patients with high-deductible plans, those in the deductible or doughnut hole phase of their plans, the government as a payer, and all Americans in the form of higher premiums," CP3 Associate Director Inma Hernandez told CNBC. Hernandez spoke about a recent study she led which found that name-brand drug prices are rising faster than inflation.